Penn Medicine Provider
Thoracic Surgery
John C. Kucharczuk, MD
5.0
(712)
Accepting new patients
Sees patients age 18 and up
Penn Thoracic Surgery West Chester
View 2 additional locations

About me

  • Director, Thoracic Oncology Network, Abramson Cancer Center
  • Director, Integrated Thoracic Oncology Program
  • Carole and Stuart Potter Associate Professor in BRCA Clinical Care

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

716 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
excellent doctor
May 2025
5.0
5.0
a true professional
April 2025
5.0
5.0
very happy with him
April 2025
5.0
5.0
dr k has guided me thru for four years. he is kind and caring very professional. goes above and beyond.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Kucharczuk is a Penn Medicine physician.

Qualifications and experience

My research

Kucharczuk JC, Kaiser LR Bronchoplastic procedures , Robb & Smith's Operative Surgery: 2023 (in press)


Kucharczuk JC, Kaiser LR Flexible and rigid bronchoscopy , Robb & Smith's Operative Surgery: 2023 (in press)


Simone CB, Yegya-Raman N, Manjunath S, Verma V, Shabason JE, Xu L, Cengel KA, Levin WP, Berman AT, Christodouleas JP, Aggarwal C, Cohen RB, Langer CJ, Pechet TT, Singal S, Kucharczuk JC, Rengan R, Feigenberg SJ Prospective feasibility and phase I/II trial of preoperative proton beam therapy with concurrent chemotherapy for resectable stage IIIA or superior sulcus non-small cell lung cancer , International Journal of Radiation Oncology Biology Physics: 2023 (Epub)


Azari F, Zhang K, Kennedy G, Bou-Samra P, Chang A, Nadeem B, Chang A, Galandarova A, Ibrahimli A, Karimov Z, Din A, Kucharczuk J, Doraid J, Pechet T, Delikatny E, Singhal S Prospective validation of tumor folate receptor expression density with the association of pafolacianine fluorescence during intraoperative molecular imaging-guided lung cancer resections , European Journal of Nuclear Medicine & Molecular Imaging, 50(8): 2023,2453-2465


Kennedy GT, Azari FS, Chang A, Nadeem B, Bernstein E, Segil A, Din A, Desphande C, Okusanya O, Keating J, Predina J, Newton A, Kucharczuk JC, Singhal S Single-institution experience of 500 pulmonary resections guided by intraoperative molecular imaging , Journal of Thoracic & Cardiovascular Surgery, 165(6): 2023,1928-1938.e1


Kim KN, Heintz J, Yegya-Raman N, Cohen R, Kegelman T, Cengel K, Marmarelis M, Sun L, Langer C, Aggarwal C, Singh A, Singhal S, Kucharczuk J, Robinson K, Feigenberg S Toxicities and deaths from intercurrent disease following contemporary postoperative radiotherapy in resected non-small-cell lung cancer , Clinical Lung Cancer, 24(2): 2023,e78-e86


Kennedy GT, Azari FS, Bernstein E, Deshpande C, Kucharczuk JC, Delikatny EJ, Singhal S Three-dimensional near-infrared specimen mapping can identify the distance from the tumor to the surgical margin during resection of pulmonary ground glass opacities , Molecular Imaging & Biology, 25(1): 2023,203-211


Azari F, Kennedy G, Bernstein E, Delikatny J, Lee JYK, Kucharczuk J, Low PS, Singhal S Evaluation of OTL38-generated tumor-to-background ratio in intraoperative molecular imaging-guided lung cancer resections , Molecular Imaging & Biology, 25(1): 2023,85-96


Azari F, Kennedy G, Zhang K, Bernstein E, Chang A, Nadeem B, Segil A, Desphande C, Delikatny J, Kucharczuk J, Singhal S Effects of light-absorbing carbons in intraoperative molecular imaging-guided lung cancer resections , Molecular Imaging & Biology, 25(1): 2023,156-167


Azari F, Meijer RPJ, Kennedy GT, Hanna A, Chang A, Nadeem B, Din A, Pèlegrin A, Framery B, Cailler F, Sullivan NT, Kucharczuk J, Martin LW, Vahrmeijer AL, Singhal S Carcinoembryonic antigen-related cell adhesion molecule type 5 receptor-targeted fluorescent intraoperative molecular imaging tracer for lung cancer: A nonrandomized controlled trial , JAMA Network Open, 6(1): 2023,e2252885